• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Hospital Uses Google Glass To Diagnose Skin Conditions

by Fred Pennic 04/16/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Hospital Uses Google Glass To Diagnose Skin Conditions
Credit: William Murphy, Rhode Island Hospital
A team of physicians at Rhode Island Hospital conducted a research trail with Google Glass to gauge the effectiveness, security and patient acceptance of a real-time, video skin consultation. The study began in March, 2014 and concluded after six months. The research results were recently published this week in JAMA Dermatology.

Study Overview

For the patients who qualified for the trial, the emergency department physicians at the Rhode Island Hospital used Google Glass to contact a dermatologist through a video link using Glass and utilizing Pristine’s HIPAA compliant platform. Medical staff explained to patients that no information was being stored, and the live transmission was encrypted. After the consultation, patients were surveyed about their experience with teledermatology. Patients reported that while they prefer in-person visits, they preferred the video consult over the traditional phone consult. They also reported that they felt their information was safe. 

Study Limitations

The study did report several limitations including: – Because of the small size and single-site status, results cannot be generalized to other institutions; – the accuracy of the diagnosis in the cases wasn’t measured – financial and workflow effects of the device weren’t addressed “A device like this democratises telemedicine because a hospital can start a programme with little money and gain access to an experience that was only previously available at a much higher price point,” said Paul S Porter, principal investigator. Because of the interactive nature of using Glass, the teledermatologists were able to appreciate both non-specific skin eruptions and skin diseases. Additionally, the off-site doctors were able to interact with the on-site doctors by asking questions and requesting additional skin locations to examine. Rhode Island Hospital was the first hospital in the US to test Google Glass in an emergency department setting.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

M&A: ResMed to Sell MatrixCare Business to Frazier Healthcare Partners for $450M

The Real Risk in Healthcare AI Isn’t the Model. It’s the Data. 

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |